Atlas Trials

Clinical Study of CN128 in Thalassemia Patients

Clinical trial NCT03673085 · COMPLETED

Trial details

NCT number
NCT03673085
Sponsor
Hangzhou Zede Pharma-Tech Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Thalassemia
Start date
2018-01-05
Primary completion
2018-10-16
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.